Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons

NCT02572323 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT02572323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02572323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Completed
Start date
February 15, 2017
Completion date
October 15, 2023
Enrollment
73 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment